questionsmedicales.fr
Infection
Infections bactériennes et mycoses
Infections bactériennes
Infections bactériennes à Gram positif
Infections à Actinomycetales
Infections à Mycobacterium
Infections à mycobactéries non tuberculeuses
Lèpre
Lèpre : Questions médicales fréquentes
Termes MeSH sélectionnés :
Multicenter Studies as Topic
Symptômes
5
Lèpre
Évolution des maladies
Traitements
5
Lèpre
Durée du traitement
Complications
5
Lèpre
Gestion des complications
Facteurs de risque
5
Lèpre
Statut socio-économique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lèpre : Questions médicales les plus fréquentes",
"headline": "Lèpre : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lèpre : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lèpre"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à mycobactéries non tuberculeuses",
"url": "https://questionsmedicales.fr/mesh/D009165",
"about": {
"@type": "MedicalCondition",
"name": "Infections à mycobactéries non tuberculeuses",
"code": {
"@type": "MedicalCode",
"code": "D009165",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.475"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lèpre multibacillaire",
"alternateName": "Leprosy, Multibacillary",
"url": "https://questionsmedicales.fr/mesh/D056006",
"about": {
"@type": "MedicalCondition",
"name": "Lèpre multibacillaire",
"code": {
"@type": "MedicalCode",
"code": "D056006",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.475.371.775"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lèpre lépromateuse",
"alternateName": "Leprosy, Lepromatous",
"url": "https://questionsmedicales.fr/mesh/D015440",
"about": {
"@type": "MedicalCondition",
"name": "Lèpre lépromateuse",
"code": {
"@type": "MedicalCode",
"code": "D015440",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.475.371.775.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Lèpre paucibacillaire",
"alternateName": "Leprosy, Paucibacillary",
"url": "https://questionsmedicales.fr/mesh/D056005",
"about": {
"@type": "MedicalCondition",
"name": "Lèpre paucibacillaire",
"code": {
"@type": "MedicalCode",
"code": "D056005",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.475.371.850"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Lèpre interpolaire",
"alternateName": "Leprosy, Borderline",
"url": "https://questionsmedicales.fr/mesh/D015439",
"about": {
"@type": "MedicalCondition",
"name": "Lèpre interpolaire",
"code": {
"@type": "MedicalCode",
"code": "D015439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.475.371.850.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lèpre tuberculoïde",
"alternateName": "Leprosy, Tuberculoid",
"url": "https://questionsmedicales.fr/mesh/D015441",
"about": {
"@type": "MedicalCondition",
"name": "Lèpre tuberculoïde",
"code": {
"@type": "MedicalCode",
"code": "D015441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.150.252.410.040.552.475.371.850.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lèpre",
"alternateName": "Leprosy",
"code": {
"@type": "MedicalCode",
"code": "D007918",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Euzenir Nunes Sarno",
"url": "https://questionsmedicales.fr/author/Euzenir%20Nunes%20Sarno",
"affiliation": {
"@type": "Organization",
"name": "Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil."
}
},
{
"@type": "Person",
"name": "Wim H van Brakel",
"url": "https://questionsmedicales.fr/author/Wim%20H%20van%20Brakel",
"affiliation": {
"@type": "Organization",
"name": "NLR, Amsterdam, Netherlands."
}
},
{
"@type": "Person",
"name": "Tarun Narang",
"url": "https://questionsmedicales.fr/author/Tarun%20Narang",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."
}
},
{
"@type": "Person",
"name": "Sunil Dogra",
"url": "https://questionsmedicales.fr/author/Sunil%20Dogra",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India."
}
},
{
"@type": "Person",
"name": "Mariana Andrea Hacker",
"url": "https://questionsmedicales.fr/author/Mariana%20Andrea%20Hacker",
"affiliation": {
"@type": "Organization",
"name": "Leprosy Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil. marianah@ioc.fiocruz.br."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Topical sirolimus solution for lingual microcystic lymphatic malformations in children and adults (TOPGUN): study protocol for a multicenter, randomized, assessor-blinded, controlled, stepped-wedge clinical trial.",
"datePublished": "2022-07-08",
"url": "https://questionsmedicales.fr/article/35804404",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13063-022-06365-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Access to rehabilitation after stroke in Brazil (AReA study): multicenter study protocol.",
"datePublished": "2022-12-19",
"url": "https://questionsmedicales.fr/article/36535291",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0042-1758558"
}
},
{
"@type": "ScholarlyArticle",
"name": "Surgical Outcomes of Primary Dermatofibrosarcoma Protuberans: A Retrospective, Multicenter Study.",
"datePublished": "2022-08-06",
"url": "https://questionsmedicales.fr/article/35933538",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1245/s10434-022-12351-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study Protocol of a Prospective Multicenter Observational Study Evaluating Acute Lower Limb Ischemia.",
"datePublished": "2022-11-05",
"url": "https://questionsmedicales.fr/article/36347128",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2022.09.023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Study protocol of Branch Atheromatous Disease-related stroke (BAD-study): a multicenter prospective cohort study.",
"datePublished": "2022-12-09",
"url": "https://questionsmedicales.fr/article/36494618",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12883-022-02976-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Infections bactériennes et mycoses",
"item": "https://questionsmedicales.fr/mesh/D001423"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections bactériennes",
"item": "https://questionsmedicales.fr/mesh/D001424"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections bactériennes à Gram positif",
"item": "https://questionsmedicales.fr/mesh/D016908"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à Actinomycetales",
"item": "https://questionsmedicales.fr/mesh/D000193"
},
{
"@type": "ListItem",
"position": 7,
"name": "Infections à Mycobacterium",
"item": "https://questionsmedicales.fr/mesh/D009164"
},
{
"@type": "ListItem",
"position": 8,
"name": "Infections à mycobactéries non tuberculeuses",
"item": "https://questionsmedicales.fr/mesh/D009165"
},
{
"@type": "ListItem",
"position": 9,
"name": "Lèpre",
"item": "https://questionsmedicales.fr/mesh/D007918"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lèpre - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lèpre",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lèpre",
"description": "Comment diagnostique-t-on la lèpre ?\nQuels tests sont utilisés pour la lèpre ?\nLa lèpre est-elle contagieuse ?\nQuels signes cliniques indiquent la lèpre ?\nPeut-on détecter la lèpre par des analyses sanguines ?",
"url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Multicenter+Studies+as+Topic#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lèpre",
"description": "Quels sont les symptômes de la lèpre ?\nLa lèpre cause-t-elle des douleurs ?\nLes lésions de la lèpre sont-elles douloureuses ?\nComment évoluent les symptômes de la lèpre ?\nPeut-on avoir des symptômes sans être contagieux ?",
"url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Multicenter+Studies+as+Topic#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lèpre",
"description": "Comment prévenir la lèpre ?\nLes vaccins protègent-ils contre la lèpre ?\nFaut-il éviter les personnes atteintes de lèpre ?\nQuelles mesures de santé publique sont prises ?\nLa lèpre est-elle une maladie évitable ?",
"url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Multicenter+Studies+as+Topic#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lèpre",
"description": "Quel est le traitement de la lèpre ?\nLa lèpre peut-elle être guérie ?\nCombien de temps dure le traitement de la lèpre ?\nY a-t-il des effets secondaires au traitement ?\nLe traitement de la lèpre est-il gratuit ?",
"url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Multicenter+Studies+as+Topic#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lèpre",
"description": "Quelles sont les complications de la lèpre ?\nLa lèpre peut-elle entraîner des handicaps ?\nLes complications sont-elles réversibles ?\nComment gérer les complications de la lèpre ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Multicenter+Studies+as+Topic#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lèpre",
"description": "Qui est à risque de développer la lèpre ?\nL'immunité joue-t-elle un rôle dans la lèpre ?\nLes enfants sont-ils plus à risque ?\nLe statut socio-économique influence-t-il le risque ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?",
"url": "https://questionsmedicales.fr/mesh/D007918?mesh_terms=Multicenter+Studies+as+Topic#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la lèpre ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et des tests cutanés pour détecter les bacilles."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour la lèpre ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de sensibilité cutanée et des biopsies peuvent être réalisés pour confirmer la lèpre."
}
},
{
"@type": "Question",
"name": "La lèpre est-elle contagieuse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La lèpre n'est pas très contagieuse; elle se propage par contact prolongé avec une personne infectée."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent la lèpre ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des lésions cutanées, des engourdissements et des déformations peuvent indiquer la lèpre."
}
},
{
"@type": "Question",
"name": "Peut-on détecter la lèpre par des analyses sanguines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses sanguines ne sont pas spécifiques; le diagnostic repose principalement sur l'examen clinique."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la lèpre ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des lésions cutanées, des engourdissements et des douleurs nerveuses."
}
},
{
"@type": "Question",
"name": "La lèpre cause-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la lèpre peut provoquer des douleurs nerveuses et des sensations anormales."
}
},
{
"@type": "Question",
"name": "Les lésions de la lèpre sont-elles douloureuses ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les lésions cutanées sont souvent indolores, mais peuvent s'infecter et causer des douleurs."
}
},
{
"@type": "Question",
"name": "Comment évoluent les symptômes de la lèpre ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent évoluer lentement, avec des périodes d'aggravation et d'amélioration."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans être contagieux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une personne peut avoir des symptômes sans être contagieuse, surtout en début d'infection."
}
},
{
"@type": "Question",
"name": "Comment prévenir la lèpre ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention repose sur le dépistage précoce et le traitement des personnes infectées."
}
},
{
"@type": "Question",
"name": "Les vaccins protègent-ils contre la lèpre ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de vaccin spécifique contre la lèpre, mais des recherches sont en cours."
}
},
{
"@type": "Question",
"name": "Faut-il éviter les personnes atteintes de lèpre ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, avec un traitement, les personnes atteintes ne sont plus contagieuses et peuvent être approchées."
}
},
{
"@type": "Question",
"name": "Quelles mesures de santé publique sont prises ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des campagnes de sensibilisation et de dépistage sont mises en place pour contrôler la lèpre."
}
},
{
"@type": "Question",
"name": "La lèpre est-elle une maladie évitable ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la lèpre est évitable grâce à un diagnostic précoce et un traitement adéquat."
}
},
{
"@type": "Question",
"name": "Quel est le traitement de la lèpre ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard est une polychimiothérapie (PCT) avec des antibiotiques comme la rifampicine."
}
},
{
"@type": "Question",
"name": "La lèpre peut-elle être guérie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la lèpre est curable avec un traitement approprié et précoce."
}
},
{
"@type": "Question",
"name": "Combien de temps dure le traitement de la lèpre ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dure généralement de 6 mois à 2 ans, selon la forme de la maladie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires au traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets secondaires peuvent survenir, mais ils sont généralement légers et gérables."
}
},
{
"@type": "Question",
"name": "Le traitement de la lèpre est-il gratuit ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans de nombreux pays, le traitement de la lèpre est gratuit et accessible."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la lèpre ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions nerveuses, des déformations et des infections secondaires."
}
},
{
"@type": "Question",
"name": "La lèpre peut-elle entraîner des handicaps ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lésions nerveuses peuvent causer des handicaps permanents si non traitées."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement précoce, d'autres non."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications de la lèpre ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical et des soins adaptés aux lésions."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Qui est à risque de développer la lèpre ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones endémiques et celles en contact avec des malades sont à risque."
}
},
{
"@type": "Question",
"name": "L'immunité joue-t-elle un rôle dans la lèpre ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une immunité affaiblie augmente le risque de développer la lèpre."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent être à risque, mais la maladie touche principalement les adultes."
}
},
{
"@type": "Question",
"name": "Le statut socio-économique influence-t-il le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un faible statut socio-économique est associé à un risque accru de lèpre."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées ont un risque accru de contracter la lèpre."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Publications dans "Lèpre" :
4 publications dans cette catégorie
Affiliations :
NLR, Amsterdam, Netherlands.
Publications dans "Lèpre" :
3 publications dans cette catégorie
Affiliations :
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Publications dans "Lèpre" :
3 publications dans cette catégorie
Affiliations :
Department of Dermatology, Venereology, and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Publications dans "Lèpre" :
3 publications dans cette catégorie
Affiliations :
Leprosy Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil. marianah@ioc.fiocruz.br.
Publications dans "Lèpre" :
3 publications dans cette catégorie
Affiliations :
Department of Dermatology and Venereology, Faculty of Medicine, Padjadjaran University, Dr Hasan Sadikin Hospital, Bandung, Indonesia.
Publications dans "Lèpre" :
3 publications dans cette catégorie
Affiliations :
Department of Dermatology and Venereology, Faculty of Medicine, Padjadjaran University, Dr Hasan Sadikin Hospital, Bandung, Indonesia.
Publications dans "Lèpre" :
3 publications dans cette catégorie
Affiliations :
Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Publications dans "Lèpre" :
3 publications dans cette catégorie
Affiliations :
Institute for Specialized Services in Leprosy (INSSIL), Nireekshana ACET, Hyderabad, Telangana, India.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Leprosy Laboratory, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Global Health Institute, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO, USA.
Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Leprosy Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Avenida Brasil 4365, Manguinhos, Rio de Janeiro, RJ, 21040-360, Brazil.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Department of Dermatology and Venereology, Faculty of Medicine, Padjadjaran University, Dr Hasan Sadikin Hospital, Bandung, Indonesia.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Instituto Colombiano de Medicina Tropical-Universidad CES, Medellín, Colombia.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Instituto Colombiano de Medicina Tropical-Universidad CES, Medellín, Colombia.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Haramaya University, College of Health and Medical Sciences, Harar, Ethiopia.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
Armauer Hansen Research Institute, Addis Ababa, Ethiopia.
Publications dans "Lèpre" :
2 publications dans cette catégorie
Affiliations :
College of Health and Medical Sciences, Department of Nursing, Meda Walebu University, Shashamane, Ethiopia.
Publications dans "Lèpre" :
Lingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations presenting as clusters of cysts filled with lymph fluid or blood. Even small well-limited lesions can be ...
This is a randomized, multicentric study using an individually randomized stepped-wedge design over 24 weeks to evaluate topical application of a 1 mg/mL sirolimus solution once daily, on LMLM, versus...
Given the disappointing state of current treatment options in LMLMs, topical sirolimus could become firstline therapy in treating LMLMs if its efficacy and safety were to be demonstrated....
ClinicalTrials.gov NCT04128722 . Registered on 24 September 2019. EudraCT: EUCTR2019-001530-33-FR Sponsor (University Hospital Center of Tours - CHRU Tours): DR190041-TOPGUN French regulatory authorit...
Most of the Brazilian population relies on public healthcare and stroke is a major cause of disability in this country of continental dimensions. There is limited information about access to rehabilit...
To provide comprehensive information about Access to Rehabilitation After discharge from public hospitals in Brazil (AReA study), up to 6 months after stroke....
The present study intends to collect information from 17 public health centers in 16 Brazilian cities in the 5 macroregions of the country. Each center will include 36 participants (...
The study is ongoing. Recruitment started on January 31...
The AReA study will fill a gap in knowledge about access to stroke rehabilitation in the public health system in different Brazilian regions....
Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive tumor with a low rate of metastatic disease. Previous series have shown a superiority of Mohs micrographic surgery (MMS) compared with wi...
The purpose of the current study was to examine the outcome of surgical treatment of primary DFSP of the trunk and extremities....
We reviewed 236 patients (115 females, 121 males, mean age 41 ± 15 years) undergoing MMS (n = 81, 34%) or WLE (n = 155, 66%) to treat a primary DFSP. Mean tumor size and follow-up was 4 ± 2 cm and 7 y...
There was no difference (p > 0.05) in patient age, sex, tumor size, negative margin excision, or history of a previous inadvertent excision between patients who underwent WLE and those undergoing MMS....
There was no difference in oncologic outcome comparing MMS with WLE for DFSP outside the head and neck. The goal of treatment for DFSP is to achieve a negative margin, regardless of surgical treatment...
Acute lower limb ischemia (ALI) is a limb- and potentially life-threatening condition which requires urgent evaluation and treatment. Contemporary data on optimal therapy and prognosis of ALI are lack...
The proposed study is a prospective, international, multicenter, observational study on ALI (PROMOTE-ALI) (ClinicalTrials.gov - NCT05138679). Patients with ALI (Rutherford classification grade I -III)...
ALI remains a challenging condition and due to the heterogeneous etiology, clinical presentation and treatment strategies, a large multicenter study on this topic is needed to gain contemporary data o...
As a meaningful subtype of ischemic stroke in Asians, Branch atheromatous disease (BAD)-related stroke is associated with high early neurological deterioration (END) and disability, but is understudie...
BAD-study is a nationwide, multicenter, consecutive, prospective, observational cohort study enrolling patients aged 18-80 years with BAD-related stroke within 72 h after symptom onset. Initial clinic...
BAD-study can provide demographic, clinical, radiological, and prognostic characteristics of BAD-related stroke, and thereby potentially figure out the vascular mechanism of early neurological deterio...
Narrowband ultraviolet B (NB-UVB) phototherapy is commonly prescribed for patients with moderate-to-severe atopic eczema (AE). The efficacy of NB-UVB, however, has not yet properly been established, a...
A pragmatic, multicenter, PROBE trial will be performed with 1:1 randomization of 316 adult patients with moderate-to-severe AE who have inadequate disease control with topical therapy and who are eli...
The UPDATE trial aims to provide high-quality evidence regarding the (cost-)effectiveness and safety of NB-UVB phototherapy in moderate-to-severe AE patients. Challenges that are addressed in the prot...
ClinicalTrials.gov NCT05704205. Registered on December 8, 2022....
Epidemiological data on cerebral venous thrombosis in China are still lacking at present on the aspects of incidence, recurrence, risk factors, and so on. Herein, we aimed to fill the gap, based on th...
Rectal cancer is a common cancer worldwide. Surgery for rectal cancer with low anterior resection often includes the formation of a temporary protective loop ileostomy. The temporary ostomy is later r...
The present multicenter, double-blinded, randomized, controlled study will compare standard suture closure of the abdominal wall in loop ileostomy reversal with retromuscular synthetic mesh at the sto...
This double-blinded randomized controlled superiority study will compare retromuscular synthetic mesh during the closure of loop ileostomy to standard care. If this study can show a lower frequency of...
ClinicalTrials.gov NCT03720262. Registered on October 25, 2018....
Multicenter contemporary data describing short-term outcomes after initial interventions of neonates with pulmonary atresia with intact ventricular septum (PA-IVS) are limited. This multicenter study ...
Neonates with PA-IVS who underwent surgical or catheter intervention between 2009 and 2019 in 19 centers were reviewed. Risk factors for MACE, defined as cardiopulmonary resuscitation, mechanical circ...
We reviewed 279 neonates: 79 (28%) underwent right ventricular decompression, 151 (54%) underwent systemic-to-pulmonary shunt or ductal stent placement only, 36 (13%) underwent right ventricular decom...
In a multicenter cohort, 1 in 5 neonates with PA-IVS experienced MACE after their initial intervention. Patients with 2 major coronary artery stenoses or lower weight at the time of the initial proced...
Cases of Toxoplasma reactivation or more severe primary infection have been reported in patients receiving immunosuppressive (IS) treatment for autoimmune diseases (AID). The purpose of this study was...
A multicenter descriptive study was conducted using data from the French National Reference Center for Toxoplasmosis (NRCT) that received DNA extracts or strains isolated from patients, associated wit...
61 cases were collected: 25 retrieved by the NRCT and by a call for observations and 36 from a literature review. Half of the cases were attributed to reactivation (50.9%), and most of cases (49.2%) w...
Although this remains a rare condition, clinicians should be aware for the management of patients and for the choice of IS treatment....